Form 8-K Dolby Laboratories, Inc. For: Oct 31

�

�

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

�

�

FORM 8-K

�

�

CURRENT REPORT

Pursuant to Section�13 or 15(d)

of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):

October�31, 2014

�

�

DOLBY LABORATORIES, INC.

(Exact name of registrant as specified in its charter)

�

�

�

Delaware	�	001-32431	�	90-0199783
(State or other jurisdiction of incorporation)	�	(Commission File Number)	�	(IRS Employer Identification No.)

100 Potrero Avenue

San Francisco, CA 94103-4813

(Address of principal executive offices) (Zip Code)

(415) 558-0200

(Registrant�s telephone number, including area code)

Not Applicable

(Former name or former address, if changed since last report)

�

�

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

�

�	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

�

�	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

�

�	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

�

�	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

�

�

�

---

Section 8 � Other Events

�

Item�8.01

Other Events.

On October�31, 2014, Dolby Laboratories, Inc. completed its acquisition of Doremi Labs. The press release announcing the completion of the transaction is attached as Exhibit 99.1.

Section 9 � Financial Statements and Exhibits

�

Item�9.01

Financial Statements and Exhibits.

(d) Exhibits.

�

Exhibit No.	��	Description
99.1	��	Press Release of Dolby Laboratories, Inc. dated November 3, 2014

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

�

Date: November�3, 2014

---

EXHIBIT INDEX

�

Exhibit No.	��	Description
99.1	��	Press Release of Dolby Laboratories, Inc. dated November 3, 2014

Exhibit 99.1

Media Contact:

Sean Durkin

Dolby Laboratories

415-645-5176

[email protected]

Dolby Acquires Doremi Labs

San Francisco, November�3, 2014�Dolby Laboratories, Inc. (NYSE: DLB) has completed its acquisition of Doremi Labs. The deal advances Dolby�s mission to improve the cinema experience, enable new forms of storytelling, and accelerate the delivery and deployment of innovative solutions to exhibitors.

The acquisition establishes Dolby as a leader in audio and video playback solutions with a comprehensive product portfolio for the cinema exhibition industry.

�We are thrilled to bring together two teams that are committed to delivering the best digital cinema processing and playback solutions,� said Kevin Yeaman, President and CEO, Dolby Laboratories. �Delivering deeply integrated audio/video playback solutions will allow us to accelerate innovation and deliver amazing experiences for exhibitors and audiences.�

About Dolby Laboratories

Dolby Laboratories (NYSE: DLB) creates audio, video, and voice technologies that transform entertainment and communications in mobile devices, at the cinema, at home, and at work. For nearly 50 years, sight and sound experiences have become more vibrant, clear, and powerful in Dolby^�. For more information, please visit www.dolby.com.

Dolby and the double-D symbol are registered trademarks of Dolby Laboratories. S14/28380 DLB-G

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Holcim US Celebrates Recipients of the 2024 Gygi and von Wyss Foundation Scholarship
• Obsidian Therapeutics to Present Clinical Data from OBX-115, its Engineered TIL Cell Therapy, for Patients with Advanced Solid Tumors in Oral Presentation at the 2024 ASCO Annual Meeting
• UGI to Continue System Upgrades in Manheim Township Starting May 1